Induction of Foxp3 expression in T cells by cellulose acetate beads in vitro

Journal of Clinical Apheresis

Volumn 25, Issue 4, 2010, Pages 216-222

  Jimma, Fumie ^a,b   Takeda, Yuji ^a,c   Kaneda, Kenta ^a   Wakabayashi, Ichiro ^c  

^a JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^b On Chip Biotechnologies Co Ltd   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Cellulose acetate; Foxp3; Inflammatory bowel disease; Regulatory T cell; TGF 1

Indexed keywords

CELLULOSE ACETATE; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

APHERESIS; ARTICLE; CD3+ T LYMPHOCYTE; CELL CULTURE; COCULTURE; CONTROLLED STUDY; GRANULOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE;

ANTIGENS, CD3; BLOOD COMPONENT REMOVAL; CELLULOSE; COCULTURE TECHNIQUES; COLITIS, ULCERATIVE; FORKHEAD TRANSCRIPTION FACTORS; GRANULOCYTES; HUMANS; IMMUNOPHENOTYPING; MICROSPHERES; MONOCYTES; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 77956283673     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20243     Document Type: Article

References (32)

1. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-787.
2. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-562.
3. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061. (Pubitemid 36222930)
4. Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK. The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology 2008;125:145-153.
5. Morgan ME, Sutmuller RP, Witteveen HJ, Van Duivenvoorde LM, Zanelli E, Melief CJ, Snijders A, Offringa R, De Vries RR, Toes RE. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 2003;48: 1452-1460. (Pubitemid 36554546)
6. Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh DI. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 2006;177:1451-1459. (Pubitemid 44092478)
7. + regulatory T cells for the treatment of inflammatory bowel diseases. Expert Opin Biol Ther 2005;5:451-462.
8. Saniabadi AR, Hanai H, Suzuki Y, Ohmori T, Sawada K, Yoshimura N, Saito Y, Takeda Y, Umemura K, Kondo K, Ikeda Y, Fukunaga K, Nakashima M, Beretta A, Bjarnason I, Lofberg R. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy? J Clin Apher 2005;20:171-184.
9. Nagashima M, Yoshino S, Tanaka H, Yoshida N, Kashiwagi N, Saniabadi AR. Granulocyte and monocyte apheresis suppresses symptoms of rheumatoid arthritis: a pilot study. Rheumatol Int 1998;18:113-118. (Pubitemid 28505333)
10. Okawa-Takatsuji M, Nagatani K, Nakajima K, Itoh K, Kano T, Nagashio C, Takahashi Y, Aotsuka S, Mimori A. Recruitment of immature neutrophils in peripheral blood following leukocytapheresis therapy for rheumatoid arthritis. J Clin Apher 2007; 22:323-329. (Pubitemid 351219766)
11. + T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis. Dig Dis Sci 2007;52:2725-2731.
12. Cuadrado E, Alonso M, De Juan MD, Echaniz P, Arenas JI. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis. World J Gastroenterol 2008;14:1521-1527. (Pubitemid 351460165)
13. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886.
14. - T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004;172:5149-5153.
15. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 2006;24:99-146.
16. + regulatory T cells suppress Th1 mediated experimental colitis. Gut 2006;55:671-680.
17. Gorelik LFlavell RA. Transforming growth factor-β in T-cell biology. Nat Rev Immunol 2002;2:46-53. (Pubitemid 37328775)
18. +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-b dependent but does not confer a regulatory phenotype. Blood 2007;110:2983-2990.
19. Takeda Y, Shiobara N, Saniabadi AR, Adachi M, Hiraishi K. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and β2 integrin. Inflamm Res 2004;53:277-283. (Pubitemid 38969357)
20. Hiraishi K, Takeda Y, Shiobara N, Shibusawa H, Jimma F, Kashiwagi N, Saniabadi AR, Adachi M. Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Ther Apher Dial 2003;7:334-340. (Pubitemid 36859523)
21. Fava RA, Casey TT, Wilcox J, Pelton RW, Moses HL, Nanney LB. Synthesis of transforming growth factor-β1 by megakaryocytes and its localization to megakaryocyte and platelet α-granules. Blood 1990;76:1946-1955.
22. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991;78:1730-1737.
23. Theoret JF, Bienvenu JG, Kumar A, Merhi Y. P-selectin antagonism with recombinant p-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfaces. J Pharmacol Exp Ther 2001;298:658-664. (Pubitemid 32673417)
24. + regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci USA 2004;101:4572-4577.
25. + regulatory T cells and immune tolerance. Autoimmunity 2006;39:269-276.
26. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J Clin Invest 2002;109:41-50.
27. Xiao YQ, Freire-De-Lima CG, Schiemann WP, Bratton DL, Vandivier RW, Henson PM. Transcriptional and translational regulation of TGF-β production in response to apoptotic cells. J Immunol 2008;181:3575-3585.
28. La Sala A, Gadina M, Kelsall BL. G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK. J Immunol 2005;175:2994-2999. (Pubitemid 41170517)
29. Nishise S, Takeda Y, Nishise Y, Fujishima S, Orii T, Otake S, Sato T, Sasaki Y, Takeda H, Kawata S. Biological effect of anaphylatoxin C5a on the generation of anti-inflammatory substances in leukocyte adsorption. Ther Apher Dial 2009;13:509-514.
30. Nishise S, Takeda Y, Takeda H, Ishihama K, Fukui T, Kawata S. Complement activation is involved in biological responses to leukocyte adsorptive apheresis. Dig Dis Sci 2006;51:934-941. (Pubitemid 44030818)
31. Nishise S, Takeda Y, Fujishima S, Orii T, Sato T, Sasaki Y, Nishise Y, Takeda Y, Kawata S. Release of interleukin 1 receptor antagonist by combining a leukocyte adsorption carrier with ulinastatin. Ther Apher Dial, in press.
32. low/neg accessory cells with dendritic-cell features. Blood 2006;108:218-227.